EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders

Edoardo Agosti iD, Marco Zeppieri iD, Sara Antonietti, Luigi Battaglia iD, Tamara Ius iD, Caterina Gagliano iD, Marco Maria Fontanella iD, Pier Paolo Panciani

Pharmaceutics · 27.02.2024 · 16 (3) · 329

DOI: 10.3390/pharmaceutics16030329 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 27.02.2024. Verfasst von Edoardo Agosti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Piazza Sped…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione CRT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The blood–brain barrier (BBB) regulates brain substance entry, posing challenges for treating brain diseases. Traditional methods face limitations, leading to the exploration of non-invasive intranasal drug delivery. This approach exploits the direct nose-to-brain connection, overcoming BBB restrictions. Intranasal delivery enhances drug bioavailability, reduces dosage, and minimizes systemic side effects. Notably, lipid nanoparticles, such as solid lipid nanoparticles and nanostructured lipid carriers, offer advantages like improved stability and controlled release. Their nanoscale size facilitates efficient drug loading, enhancing solubility and bioavailability. Tailored lipid compositions enable optimal drug release, which is crucial for chronic brain diseases. This review assesses lipid nanoparticles in treating neuro-oncological and neurodegenerative conditions, providing insights for effective nose-to-brain drug delivery.

Methods

A systematic search was conducted across major medical databases (PubMed, Ovid MEDLINE, and Scopus) up to 6 January 2024. The search strategy utilized relevant Medical Subject Heading (MeSH) terms and keywords related to “lipid nanoparticles”, “intranasal administration”, “neuro-oncological diseases”, and “neurodegenerative disorders”. This review consists of studies in vitro, in vivo, or ex vivo on the intranasal administration of lipid-based nanocarriers for the treatment of brain diseases.

Results

Out of the initial 891 papers identified, 26 articles met the eligibility criteria after a rigorous analysis. The exclusion of 360 articles was due to reasons such as irrelevance, non-reporting selected outcomes, the article being a systematic literature review or meta-analysis, and lack of method/results details. This systematic literature review, focusing on nose-to-brain drug delivery via lipid-based nanocarriers for neuro-oncological, neurodegenerative, and other brain diseases, encompassed 60 studies. A temporal distribution analysis indicated a peak in research interest between 2018 and 2020 (28.3%), with a steady increase over time. Regarding drug categories, Alzheimer’s disease was prominent (26.7%), followed by antiblastic drugs (25.0%). Among the 65 drugs investigated, Rivastigmine, Doxorubicin, and Carmustine were the most studied (5.0%), showcasing a diverse approach to neurological disorders. Notably, solid lipid nanoparticles (SLNs) were predominant (65.0%), followed by nanostructured lipid carriers (NLCs) (28.3%), highlighting their efficacy in intranasal drug delivery. Various lipids were employed, with glyceryl monostearate being prominent (20.0%), indicating preferences in formulation. Performance assessment assays were balanced, with in vivo studies taking precedence (43.3%), emphasizing the translation of findings to complex biological systems for potential clinical applications.

Conclusions

This systematic review reveals the transformative potential of intranasal lipid nanoparticles in treating brain diseases, overcoming the BBB. Positive outcomes highlight the effectiveness of SLNs and NLCs, which are promising new approaches for ailments from AD to stroke and gliomas. While celebrating progress, addressing challenges like nanoparticle toxicity is also crucial.

Schlagwörter

Stichwörter der Autor:innen

blood–brain barrierclinical outcomesintranasal administrationlipid nanoparticlesneuro-oncological diseasesneurodegenerative disorderssystematic reviews

Autor:innen und Institutionen

  • Division of Neurosurgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Piazza Spedali Civili 1, 25123 Brescia, Italy.
  • Department of Ophthalmology, University Hospital of Udine, p.le S. Maria della Misericordia 15, 33100 Udine, Italy.
  • Department of Drug Science and Technology, University of Torino, 10124 Torino, Italy.
  • Neurosurgery Unit, Head-Neck and Neuroscience Department University Hospital of Udine, p.le S. Maria della Misericordia 15, 33100 Udine, Italy.
  • Faculty of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.
  • Eye Clinic, Catania University San Marco Hospital, Viale Carlo Azeglio Ciampi, 95121 Catania, Italy.

ORCID-Profile: Edoardo Agosti, Marco Zeppieri, Luigi Battaglia, Tamara Ius, Caterina Gagliano, Marco Maria Fontanella

Förderung

  • Fondazione CRT

Zitieren

APA

Agosti, E., Zeppieri, M., Antonietti, S., Battaglia, L., Ius, T., Gagliano, C., Fontanella, M. M., & Panciani, P. P. (2024). Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders. Pharmaceutics, 16(3), 329. https://doi.org/10.3390/pharmaceutics16030329

Vancouver

Agosti E, Zeppieri M, Antonietti S, Battaglia L, Ius T, Gagliano C, et al. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders. Pharmaceutics. 2024;16(3):329. doi:10.3390/pharmaceutics16030329

BibTeX
@article{Agosti2024,
  author = {Agosti, Edoardo and Zeppieri, Marco and Antonietti, Sara and Battaglia, Luigi and Ius, Tamara and Gagliano, Caterina and Fontanella, Marco Maria and Panciani, Pier Paolo},
  title = {Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {3},
  pages = {329},
  doi = {10.3390/pharmaceutics16030329}
}
Kostenlos starten →